332 related articles for article (PubMed ID: 21332734)
41. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
42. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
[TBL] [Abstract][Full Text] [Related]
43. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review.
Silverman SL; Landesberg R
Am J Med; 2009 Feb; 122(2 Suppl):S33-45. PubMed ID: 19187811
[TBL] [Abstract][Full Text] [Related]
44. Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.
Capsoni F; Longhi M; Weinstein R
Arthritis Res Ther; 2006; 8(5):219. PubMed ID: 17049069
[TBL] [Abstract][Full Text] [Related]
45. Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.
Bagan JV; Jiménez Y; Gómez D; Sirera R; Poveda R; Scully C
Oral Oncol; 2008 Nov; 44(11):1088-9. PubMed ID: 18396443
[TBL] [Abstract][Full Text] [Related]
46. Clinical guidelines for prevention of osteonecrosis of the jaws in patients in treatment with bisphosphonates: literature review and report of three cases.
Sarzi Amadè D; Tallarico M; Loreti MC; Montecchi PP; Niccoli A
Minerva Stomatol; 2008 Sep; 57(9):429-46. PubMed ID: 18923378
[TBL] [Abstract][Full Text] [Related]
47. Serum CTX testing.
Schwartz HC
J Oral Maxillofac Surg; 2008 Jun; 66(6):1319-20; author reply 1320. PubMed ID: 18486810
[No Abstract] [Full Text] [Related]
48. Bisphosphonate-related osteonecrosis of the jaw: tip of the iceberg.
Knight RJ; Reddy C; Rtshiladze MA; Lvoff G; Sherring D; Marucci D
J Craniofac Surg; 2010 Jan; 21(1):25-32. PubMed ID: 20072026
[TBL] [Abstract][Full Text] [Related]
49. Alveolar bone and the bisphosphonates.
Cheng A; Daly CG; Logan RM; Stein B; Goss AN
Aust Dent J; 2009 Sep; 54 Suppl 1():S51-61. PubMed ID: 19737268
[TBL] [Abstract][Full Text] [Related]
50. Atraumatic extraction of a non-vital tooth in a patient receiving long-term oral bisphosphonates.
Xiong M; Pearson A; Sabino M; Svoboda L; Ehlis E
Northwest Dent; 2010; 89(4):27-33. PubMed ID: 20860270
[No Abstract] [Full Text] [Related]
51. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
Mavrokokki T; Cheng A; Stein B; Goss A
J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
[TBL] [Abstract][Full Text] [Related]
52. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw.
Kang HS; Lee JW; Kim JS
Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007
[TBL] [Abstract][Full Text] [Related]
53. Editorial opinion versus real data and knowledge of the literature.
Marx RE
Int J Oral Maxillofac Implants; 2008; 23(4):587-8. PubMed ID: 18807554
[No Abstract] [Full Text] [Related]
54. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
Landesberg R; Wilson T; Grbic JT
Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
[TBL] [Abstract][Full Text] [Related]
55. Guidelines for treating patients taking bisphosphonates prior to dental extractions.
Rogers S; Rahman N; Ryan D; Flint S; Healy C; Stassen LF
J Ir Dent Assoc; 2010; 56(1):40. PubMed ID: 20337145
[No Abstract] [Full Text] [Related]
56. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
Favia G; Pilolli GP; Maiorano E
J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
[TBL] [Abstract][Full Text] [Related]
57. Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
Jeffcoat M; Watts NB
Gen Dent; 2008; 56(1):96-102; quiz 103-4, 111-2. PubMed ID: 18254568
[TBL] [Abstract][Full Text] [Related]
58. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
Van Poznak C; Estilo C
Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
[TBL] [Abstract][Full Text] [Related]
59. Bisphosphonates--what the dentist needs to know: practical considerations.
Fantasia JE
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):53-60. PubMed ID: 19371815
[No Abstract] [Full Text] [Related]
60. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
Ruggiero SL; Fantasia J; Carlson E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
